Publication Date: 2022-08-23
Practice Area: Patent Litigation
Industry: Pharmaceuticals
Court: U.S. District Court of Delaware
Judge: District Judge Noreika
Attorneys: For plaintiff: Gregory R. Booker, Robert M. Oakes, Douglas E. McCann, Fish & Richardson P.C., Wilmington, DE; Corrin N. Drakulich, Christina D. Brown-Marshall, Dexter S. Whitley, Fish & Richardson, P.C., Atlanta, GA; Karrie Wheatley, Fish & Richardson, P.C., Houston, TX; Elizabeth M. Flanagan, Deanna Reichel, Fish & Richardson, P.C., Minneapolis, MN; Jonathan E. Singer, Fish & Richardson, P.C., San Diego, CA; Satish Chintapalli, Chintapalli Law Firm, PLLC, Cary, NC for plaintiff.
for defendant: Timothy Devlin, Peter A. Mazur, Neil A. Benchell, Stephanie Berger, Robert Kiddie, Devlin Law Firm LLC, Wilmington, DE for defendant.
Case Number: D69932
After defendant admitted that its product met the limitations of the patents in suit, the court found it liable for infringement after defendant presented insufficient evidence to prove that the patents in suit were invalid as anticipated or obvious under the prior art.